Author

Gerlof P. Bosman

Utrecht University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell-cell communication· 1 Organism:human· 1 Assay:protein structure· 1 Research Focus:protein structure prediction· 1 Assay:proteomics· 1

Frequent Co-Authors

Geert‐Jan BoonsiD· 2 shared André C. KnulstiD· 1 shared Andrew B. WardiD· 1 shared Anna M. EhlersiD· 1 shared Arthur E. H. BentlageiD· 1 shared Barry RockxiD· 1 shared Bart L. HaagmansiD· 1 shared Gestur VidarssoniD· 1 shared

Activity by Year

2021-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

Geert‐Jan BoonsORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Asymmetrical Glyco-Engineering of Monoclonal Antibodies Provides Insights into α-Gal Immunogenicity

Gerlof P. Bosman, Anna M. Ehlers, Thomas Buckley, Justyna M. Dobruchowska, Javier Sastre Toraño, Arthur E. H. Bentlage, André C. Knulst, Gestur Vidarsson, Geert‐Jan Boons

This paper develops an enzymatic platform to synthesize diverse mAb glycoforms and uses them to study α-Gal immunogenicity and FcγR binding.

bioRxiv · Oct 27, 2026 · PreprintBiochemistry

Multimerization- and glycosylation-dependent receptor binding of SARS-CoV-2 spike proteins

Kim M. Bouwman, Ilhan Tomris, Hannah L. Turner, Roosmarijn van der Woude, Tatiana M. Shamorkina, Gerlof P. Bosman, Barry Rockx, Sander Herfst, Joost Snijder, Bart L. Haagmans, Andrew B. Ward, Geert‐Jan Boons, Robert P. de Vries

The paper demonstrates that fully glycosylated trimeric RBD proteins of SARS-CoV-2 bind more effectively to ACE2 compared to monomeric or immaturely glycosylated variants.

PLoS Pathogens · Feb 8, 2021Peer-reviewedMolecular Biology